Effect of an enkephalin-analogue (FK 33-824) on glucose tolerance in man

Details

Serval ID
serval:BIB_08E88BD1EC3F
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Effect of an enkephalin-analogue (FK 33-824) on glucose tolerance in man
Journal
Acta Endocrinologica
Author(s)
Jeanrenaud  X., Maeder  E., Del Pozo  E., Felber  J. P.
ISSN
0001-5598 (Print)
Publication state
Published
Issued date
09/1983
Volume
104
Number
1
Pages
85-90
Notes
Clinical Trial
Controlled Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Sep
Abstract
The purpose of the present work was to study the effect of a methionine-enkephalin analogue (FK 33-824) on glucose tolerance in man. Groups of 5 to 8 normal subjects were given a 0.5 mg im injection of the drug or placebo just before a 100 g oral glucose load or a 0.5 g/kg iv glucose load. In the enkephalin analogue treated subjects, diminished insulin response to glucose was observed following the oral glucose load, with insulin values significantly lower than in the controls from time 10 to 90 min, but no corresponding change in the glucose curve. This effect was not observed when glucose was given iv in another group of 5 subjects in whom the significant blunting of the insulin response was accompanied by a significant decrease in glucose tolerance. These observations demonstrate that in man, enkephalin produces a decrease in insulin secretion in response to both oral and iv glucose loads. The absence of any marked impairment in glucose tolerance in the oral test in spite of the decreased insulin response suggests that enkephalin might have an additional effect in delaying glucose absorption.
Keywords
Adult Blood Glucose/analysis Body Weight D-Ala(2),MePhe(4),Met(0)-ol-enkephalin/*pharmacology Glucagon/blood *Glucose Tolerance Test Humans Insulin/blood/secretion Male
Pubmed
Web of science
Create date
28/01/2008 11:00
Last modification date
20/08/2019 13:31
Usage data